|
Posters,
Presentations & Publications 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999-1996 Tauber
J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, LaVange
LM, Mills-Wilson MC, Kellerman DJ. Double-masked, placebo-controlled
safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic
solution for the treatment of dry eye. Cornea, 2004 Nov;23(8):784-792. Schaberg A, Ousler G, Kellerman D, LaVange L, Durham T, Yerxa B. Diquafosol tetrasodium (INS365) treatment and corneal clearing: Evidence from clinical trials. Poster presentation at the 4th Annual International Conference on the Lacrimal Gland, Tear Film, Ocular Surface and Dry Eye Syndromes. 2004 November 17-20; Fajardo, Puerto Rico. Durham TA, LaVange LM, Kellerman DJ, Schaberg AE. Improvement in subject's worst symptom associated with treatment of 2.0% diquafosol tetrasodium in two studies of dry eye disease. Poster presentation at the 4th Annual International Conference on the Lacrimal Gland, Tear Film, Ocular Surface and Dry Eye Syndromes. 2004 November 17-20; Fajardo, Puerto Rico. Smirnov D and Watson PS. Adenine nucleosides with N6-urea modifications as inhibitors of P2Y12 mediated platelet aggregation. Poster presentation at the 2004 Southeastern Regional Meeting of the American Chemical Society (SERMACS). 2004 November 13; Research Triangle Park, North Carolina, USA. Glaub E and Douglass J. Adenine nucleosides with 5'-sulfide and sulfone modifications as inhibitors of P2Y12 mediated platelet aggregation. Poster presentation at the 2004 Southeastern Regional Meeting of the American Chemical Society (SERMACS). 2004 November 13; Research Triangle Park, North Carolina, USA. deCamp JB and Plourde R Jr. Adenosine nucleosides with 5'-amino and amido modifications as inhibitors of P2Y12 mediated platelet aggregation. Poster presentation at the 2004 Southeastern Regional Meeting of the American Chemical Society (SERMACS). 2004 November 13; Research Triangle Park, North Carolina, USA. Monson BK, Rothman JS, Raizman MB. Efficacy and tolerability of ophthalmic epinastine for treatment of seasonal allergic conjunctivitis: A randomized, double-masked, active-controlled clinical trial. Poster presentation at the 2004 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI). 2004 November 12-17; Boston, Massachusetts, USA. Brazzell RK, Vix J-M, Boshoff L. Efficacy of ophthalmic epinastine for treatment of signs and symptoms of allergic conjunctivitis in cat-sensitive subjects. Poster presentation at the 2004 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI). 2004 November 12-17; Boston, Massachusetts, USA. Crean CS, Ekdert WA III, Howard JL, Polard GT, Boncek MV, Lan L, Durham T, Peterson WM. Nociceptive activity/agitation behavioral response in rats: A novel objective assay. Poster presentation at the Neuroscience 2004 34th Annual Meeting. 2004 October 23-27; San Diego, California, USA. Kellerman
DJ, Mills-Wilson M, Johnson C. Pharmacokinetics of INS37217 after
inhaled and intravenous administration in healthy volunteers.
Poster presentation at the 2004 North American Cystic Fibrosis
Conference. 2004 October 14-17; St. Louis, Missouri, USA. Poster
in PDF Boyer JL, Patel RI, Douglass JG, Cowlen M, Crean CS, Whitsell R, Peterson, W, Shaver SR, Watson PS, Krishnamoorthy R, Hechler B, Gachet C, Yerxa BR. Development of reversible P2Y12 receptor antagonists. Powerpoint presentation at the 3rd International Meeting, ADP 2004, P2 Receptors and Other, New Targets for Antithrombotic Drugs. 2004 September 16-18; Lucca, Tuscany, Italy. Abstract in PDF Douglass JG, Bednarski K, Crean CS, Shaver SR. Effects of ribose modified adenosine phosphates in models of acute and inflammatory pain. Poster presented at the 4th International Symposium of Nucleosides and Nucleotides Purines 2004 Meeting. 2004 June 6-9; Chapel Hill, North Carolina, USA. Poster in PDF Douglass JG, Patel RI, Redick CC, Jones AC, Shaver SR, Boyer JL. Lipophilic adenine nucleotides as reversible inhibitors of P2Y12-mediated platelet aggregation. Poster presented at the 4th International Symposium of Nucleosides and Nucleotides Purines 2004 Meeting. 2004 June 6-9; Chapel Hill, North Carolina, USA. Poster in PDF Patel RI, Douglass JG, Cowlen M, Crean CS, Whitsell R, Peterson W, Shaver SR, Watson PS, Krishnamoorthy R, Gachet C, Hechler B, Yerxa BR, Boyer JL. In vivo antiplatelet activity of a reversible P2Y12 receptor antagonist. Poster presented at the 4th International Symposium of Nucleosides and Nucleotides Purines 2004 Meeting. 2004 June 6-9; Chapel Hill, North Carolina, USA. Johnson FL, Turic B, Kemp R, Palcic B, Sussman R, Voelker KG, Robinette E. Improved diagnostic sensitivity for lung cancer using an automated quantitative cytology system and uridine 5'-triphosphate-induced sputum specimens. Chest. 2004 May;125 (5 Suppl): 157S-158S. Barber LD, Durham T, LaVange L, Kellerman D, Schaberg A, Sall K, Nichols K, Yerxa B. Effect of diquafosol on worst symptom of dry eye patients: focus on photophobia. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting. 2004 April 25-29; Fort Lauderdale, Florida, USA. Poster in PDF Kellerman DJ, Ousler G, Abelson M, Welch D, Mayhew A, Durham T, LaVange L, Yerxa B. Placebo-controlled evaluation of diquafosol in a controlled adverse environment (CAE). Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting. 2004 April 25-29; Fort Lauderdale, Florida, USA. Sheppard J, Alison N, Martin D, Durham T, LaVange L, Kellerman D, Yerxa B,Schaberg A. Diquafosol tetrasodium is effective in a broad spectrum of patients with dry eye. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting. 2004 April 25-29; Fort Lauderdale, Florida, USA. Farjo R, Nour M, Oulambao AB, Peterson W, Naash MI. Retinal transcriptome analysis during the resolution of retinal detachment accomplished by P2Y2 receptor agonist INS37217. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting. 2004 April 25-29; Fort Lauderdale, Florida, USA. Peral A, Hakim N, Carracedo G, Fernández I, Yerxa B, Pintor J. Nucleotidic substances increase tear lysozyme levels in New Zealand white rabbits. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2004 Annual Meeting. 2004 April 25-29; Fort Lauderdale, Florida, USA. Douglass JG, Patel RI, Redick C, Jones AC, Shaver SR, Boyer JL. Adenine mononucleotides modified with lipophilic acetal and urea moieties as reversible P2Y12 receptor antagonists. Poster presented at the 227th Annual American Chemical Society Meeting. 2004 March 28-April 1; Anaheim, California, USA. Oloff S, Khashan R, Plourde R, Tropsha A. Computational based discovery of novel antiplatelet compounds. Poster presented at the 227th Annual American Chemical Society Meeting. 2004 March 28-April 1; Anaheim, California, USA. Winther B, Henry D, Schaberg AE, Kuhn KL, Keyes-Elstein L, Kellerman DJ, Hayden FG. INS37217 nasal spray, a P2Y2 receptor agonist, as a novel treatment for common cold. Poster presented at American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting. 2004 March 19-23; San Francisco, California, USA.
Page last updated: 23-Jun-2008
|
|
|
Note:
If you are having problems opening
any of the Posters or Presentations in PDF, please refresh
your page to clear out the attempt and then, with your mouse hovering
over the link to the PDF document, right click and choose Save Target
As, choose a location on your hard drive to save the document and click
save. Once the download is complete you will be given a choice to Open,
Open Folder or Close. Click Open and the PDF should open immediately.
If you continue to have problems, please conact info@inspirepharm.com.
